Birdwatch Archive

Birdwatch Note

2023-11-27 01:58:36 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING

オミクロンの初期型の株に全員定期検査し接種者が未接種者より無症状感染も含めた陽性が少ない事を示した研究には以下の4つの研究が少なくともあり、この時期にも観察研究では感染予防効果は一定程度認められています。 https://www.nejm.org/doi/full/10.1056/NEJMc2201821 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8942308/ https://www.kireports.org/article/S2468-0249(22)01261-X/fulltext https://pubmed.ncbi.nlm.nih.gov/36777314/ 国内でも濃厚接触者等の特定対象者を全員検査し検査受け易さ等のバイアスを除いた3研究でこの時期の株で3回接種者が未接種者に比べ陽性が少ない事が一貫して確認されています↓ https://pubmed.ncbi.nlm.nih.gov/36016171/ https://pubmed.ncbi.nlm.nih.gov/35948626/ https://pubmed.ncbi.nlm.nih.gov/36435404/ なおファイザー社がこの時期の株に感染予防効果がないといったという噂は「あまり」期待できず長続きしないとCEOがいった↓の話を言い換えた噂かと思われます。 https://www.cnn.co.jp/business/35184839.html

Written by F4D2E4CA66E08B99BDDE8328BBF4C2313B853B3595C8AC38600E463328C72D9D
Participant Details

Original Tweet

Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1728905065816363473

Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.

All Information

  • ID - 1728956455175454828
  • noteId - 1728956455175454828
  • participantId -
  • noteAuthorParticipantId - F4D2E4CA66E08B99BDDE8328BBF4C2313B853B3595C8AC38600E463328C72D9D Participant Details
  • createdAtMillis - 1701050316029
  • tweetId - 1728905065816363473
  • classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
  • believable -
  • harmful -
  • validationDifficulty -
  • misleadingOther - 0
  • misleadingFactualError - 1
  • misleadingManipulatedMedia - 1
  • misleadingOutdatedInformation - 1
  • misleadingMissingImportantContext - 1
  • misleadingUnverifiedClaimAsFact - 1
  • misleadingSatire - 1
  • notMisleadingOther - 0
  • notMisleadingFactuallyCorrect - 0
  • notMisleadingOutdatedButNotWhenWritten - 0
  • notMisleadingClearlySatire - 0
  • notMisleadingPersonalOpinion - 0
  • trustworthySources - 1
  • summary
    • オミクロンの初期型の株に全員定期検査し接種者が未接種者より無症状感染も含めた陽性が少ない事を示した研究には以下の4つの研究が少なくともあり、この時期にも観察研究では感染予防効果は一定程度認められています。 https://www.nejm.org/doi/full/10.1056/NEJMc2201821 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8942308/ https://www.kireports.org/article/S2468-0249(22)01261-X/fulltext https://pubmed.ncbi.nlm.nih.gov/36777314/ 国内でも濃厚接触者等の特定対象者を全員検査し検査受け易さ等のバイアスを除いた3研究でこの時期の株で3回接種者が未接種者に比べ陽性が少ない事が一貫して確認されています↓ https://pubmed.ncbi.nlm.nih.gov/36016171/ https://pubmed.ncbi.nlm.nih.gov/35948626/ https://pubmed.ncbi.nlm.nih.gov/36435404/ なおファイザー社がこの時期の株に感染予防効果がないといったという噂は「あまり」期待できず長続きしないとCEOがいった↓の話を言い換えた噂かと思われます。 https://www.cnn.co.jp/business/35184839.html

Note Status History

createdAt timestampMillisOfFirstNonNMRStatus firstNonNMRStatus timestampMillisOfCurrentStatus currentStatus timestampMillisOfLatestNonNMRStatus mostRecentNonNMRStatus participantId
2023-11-27 01:58:36 UTC
(1701050316029)		 2023-11-27 11:30:33 UTC
(1701084633142)		 CURRENTLY_RATED_HELPFUL 2023-11-28 03:24:11 UTC
(1701141851422)		 CURRENTLY_RATED_HELPFUL 2023-11-27 11:30:33 UTC
(1701084633142)		 CURRENTLY_RATED_HELPFUL

Note Ratings

rated at rated by
2023-11-27 10:45:41 -0600 Rating Details
2023-11-27 09:21:04 -0600 Rating Details
2023-11-27 09:15:13 -0600 Rating Details
2023-11-27 06:36:23 -0600 Rating Details
2023-11-27 05:10:28 -0600 Rating Details
2023-11-27 03:53:35 -0600 Rating Details
2023-11-27 03:13:26 -0600 Rating Details
2023-11-27 01:51:09 -0600 Rating Details
2023-11-27 01:02:56 -0600 Rating Details
2023-11-27 00:57:54 -0600 Rating Details
2023-11-27 00:42:17 -0600 Rating Details
2023-11-26 23:53:45 -0600 Rating Details
2023-11-26 23:28:37 -0600 Rating Details
2023-11-26 23:20:57 -0600 Rating Details
2023-11-26 22:58:16 -0600 Rating Details
2023-11-26 22:40:48 -0600 Rating Details
2023-11-26 22:26:46 -0600 Rating Details
2023-11-26 22:23:28 -0600 Rating Details
2023-11-26 22:09:51 -0600 Rating Details
2023-11-26 22:01:25 -0600 Rating Details
2023-11-26 21:58:41 -0600 Rating Details
2023-11-26 21:52:45 -0600 Rating Details
2023-11-26 21:15:08 -0600 Rating Details
2023-11-26 21:11:06 -0600 Rating Details
2023-11-26 21:10:16 -0600 Rating Details
2023-11-26 21:02:56 -0600 Rating Details
2023-11-26 20:56:15 -0600 Rating Details
2023-11-26 20:52:33 -0600 Rating Details
2023-11-26 20:51:42 -0600 Rating Details
2023-11-26 20:49:28 -0600 Rating Details
2023-11-26 20:43:36 -0600 Rating Details
2023-11-26 20:35:49 -0600 Rating Details
2023-11-26 20:33:23 -0600 Rating Details
2023-11-26 20:26:31 -0600 Rating Details
2023-11-26 20:21:10 -0600 Rating Details
2023-11-26 20:20:15 -0600 Rating Details
2023-11-26 20:16:51 -0600 Rating Details
2023-11-28 09:45:42 -0600 Rating Details
2023-11-28 05:02:11 -0600 Rating Details
2023-11-27 17:22:06 -0600 Rating Details
2023-11-27 09:28:56 -0600 Rating Details
2023-11-27 07:38:00 -0600 Rating Details
2023-11-27 06:03:17 -0600 Rating Details
2023-11-27 04:50:35 -0600 Rating Details
2023-11-27 04:25:30 -0600 Rating Details
2023-11-27 02:33:36 -0600 Rating Details
2023-11-27 01:00:44 -0600 Rating Details
2023-11-27 00:52:33 -0600 Rating Details
2023-11-27 00:25:57 -0600 Rating Details
2023-11-27 00:07:03 -0600 Rating Details
2023-11-26 23:47:17 -0600 Rating Details
2023-11-26 22:12:28 -0600 Rating Details
2023-11-26 22:03:02 -0600 Rating Details
2023-11-26 21:26:11 -0600 Rating Details
2023-11-26 21:15:54 -0600 Rating Details
2023-11-26 20:57:42 -0600 Rating Details
2023-11-26 20:57:20 -0600 Rating Details
2023-11-26 20:55:39 -0600 Rating Details
2023-11-26 20:49:22 -0600 Rating Details
2023-11-26 20:46:20 -0600 Rating Details
2023-11-26 20:37:44 -0600 Rating Details
2023-11-26 20:32:02 -0600 Rating Details
2023-11-26 20:29:02 -0600 Rating Details
2023-11-26 20:28:41 -0600 Rating Details
2023-11-26 20:25:31 -0600 Rating Details
2023-11-26 20:24:15 -0600 Rating Details
2023-11-26 20:15:35 -0600 Rating Details
2023-11-26 20:11:42 -0600 Rating Details
2023-11-26 22:36:23 -0600 Rating Details
2023-11-26 21:42:55 -0600 Rating Details
2023-11-26 20:01:39 -0600 Rating Details
2024-04-28 23:21:50 -0500 Rating Details